A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults

NCT06237049 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

644

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human
SARS-CoV-2 Infection
COVID-19

Interventions

BIOLOGICAL: BNT162b2 (Omi XBB.1.5)/RIV
BIOLOGICAL: BNT162b2 (Omi XBB.1.5)
BIOLOGICAL: RIV
OTHER: Normal saline placebo

Sponsor

Pfizer